Enhancing DNA vaccines using modified Cholera Toxin A1 Subunit as an adjuvant
使用改良霍乱毒素 A1 亚基作为佐剂增强 DNA 疫苗
基本信息
- 批准号:7337874
- 负责人:
- 金额:$ 29.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:ADP-Ribosylation FactorsActive SitesAdjuvantAdjuvanticityAnimalsAntibody FormationAntigensAromatic Amino AcidsBindingBiological AssayCell membraneCellsChimera organismCholera ToxinClinicalClinical TrialsDNADNA VaccinesDendritic CellsDevelopmentDoseDrug FormulationsEnterotoxinsEvaluationExhibitsFaceFrequenciesGaggingGoalsGovernmentHIVHeatingHumanImmune responseIn VitroMediator of activation proteinModelingModificationMusMutationNumbersPersonsPertussis ToxinPhasePhase II Clinical TrialsPlasmidsPrimatesProteinsPurposeReporterSafetyScreening ResultSignal TransductionSolubilityThinkingTimeToxinVaccinationVaccine AdjuvantVaccinesbasecellular targetingfollow-upimmunogenicityimprovedin vivomutantplasmid DNAreceptorresearch clinical testingresponsesize
项目摘要
DESCRIPTION (provided by applicant): Vaccination using plasmid DNA has the potential to provide enhanced safety and efficacy over conventional vaccines with increased stability, and accelerated product development. Unfortunately, vaccination of primates with DNA requires multiple inoculations using excessively large doses of plasmid. The A1 domains of cholera toxin (CTA1) and the related heat-labile enterotoxin (LTA1) have demonstrated particular promise as adjuvants that can enhance the immunogenicity of DNA vaccines in small animals and may provide a necessary dose sparing effect in primates. To maximally exploit this promise, however, the activity of CTA1 or LTA1 in vivo should be improved. Our objective is to identify modifications to CTA1 or LTA1 that will enhance their activity in
vivo by pursuing the following aims: Aim 1: Identify mutations in the active site of either CTA1 or LTA1 that enhance enzymatic activity in vitro; Aim 2: Identify fusion constructs between CTA1 or LTA1 and human ARF6 that enhance enzymatic activity in vitro; and, Aim 3: Identify constructs from Aims 1, and 2 that optimally enhance the immunogenicity of a candidate SIMmac239-gag DNA vaccine in vivo.
Candidate constructs that display a minimum of 10-fold enhanced adjuvanticity in vivo will be selected for evaluation in primate studies to be proposed in phase 2. Successful candidates in phase 2 will be incorporated into candidate HIV DNA vaccines intended for clinical evaluation.
描述(由申请方提供):使用质粒DNA的疫苗接种有可能提供比常规疫苗更高的安全性和有效性,具有更高的稳定性,并加速产品开发。不幸的是,用DNA接种灵长类动物需要使用过大剂量的质粒进行多次接种。霍乱毒素(CTA 1)和相关的不耐热肠毒素(LTA 1)的A1结构域已被证明特别有希望作为佐剂,其可以增强DNA疫苗在小动物中的免疫原性,并且可以在灵长类动物中提供必要的剂量节省效应。然而,为了最大限度地利用这一前景,CTA 1或LTA 1在体内的活性应该得到改善。我们的目标是鉴定CTA 1或LTA 1的修饰,其将增强CTA 1或LTA 1的活性,
目的1:鉴定CTA 1或LTA 1活性位点中增强体外酶活性的突变;目的2:鉴定CTA 1或LTA 1与人ARF 6之间增强体外酶活性的融合构建体;以及目的3:鉴定来自目的1和2的构建体,其最佳地增强候选SIMmac 239-gag DNA疫苗的体内免疫原性。
将选择在体内显示至少10倍增强的佐剂性的候选构建体用于在拟在第2阶段中进行的灵长类动物研究中进行评价。第2阶段的成功候选疫苗将被纳入用于临床评价的候选HIV DNA疫苗。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy R Fouts其他文献
Timothy R Fouts的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy R Fouts', 18)}}的其他基金
Optimization of a DNA Subunit Regimen for an HIV Vaccine
HIV 疫苗 DNA 亚基方案的优化
- 批准号:
8810334 - 财政年份:2014
- 资助金额:
$ 29.46万 - 项目类别:
Optimization of a DNA Subunit Regimen for an HIV Vaccine
HIV 疫苗 DNA 亚基方案的优化
- 批准号:
8658372 - 财政年份:2012
- 资助金额:
$ 29.46万 - 项目类别:
Development of sG as a human vaccine against Nipah/Hendra
开发 sG 作为针对尼帕/亨德拉的人类疫苗
- 批准号:
9055627 - 财政年份:2012
- 资助金额:
$ 29.46万 - 项目类别:
Optimization of a DNA Subunit Regimen for an HIV Vaccine
HIV 疫苗 DNA 亚基方案的优化
- 批准号:
8410231 - 财政年份:2012
- 资助金额:
$ 29.46万 - 项目类别:
Optimization of a DNA Subunit Regimen for an HIV Vaccine
HIV 疫苗 DNA 亚基方案的优化
- 批准号:
8642864 - 财政年份:2012
- 资助金额:
$ 29.46万 - 项目类别:
Preclinical Development of Full Length Single Chain
全长单链的临床前开发
- 批准号:
8306726 - 财政年份:2010
- 资助金额:
$ 29.46万 - 项目类别:
Preclinical Development of Full Length Single Chain
全长单链的临床前开发
- 批准号:
8296938 - 财政年份:2010
- 资助金额:
$ 29.46万 - 项目类别:
Preclinical Development of Full Length Single Chain
全长单链的临床前开发
- 批准号:
8013359 - 财政年份:2010
- 资助金额:
$ 29.46万 - 项目类别:
Enhancing DNA vaccines using modified Bacterial Toxin A1 Subunits as adjuvants
使用改良细菌毒素 A1 亚基作为佐剂增强 DNA 疫苗
- 批准号:
7844676 - 财政年份:2007
- 资助金额:
$ 29.46万 - 项目类别:
Enhancing DNA vaccines using modified Bacterial Toxin A1 Subunits as adjuvants
使用改良细菌毒素 A1 亚基作为佐剂增强 DNA 疫苗
- 批准号:
8244560 - 财政年份:2007
- 资助金额:
$ 29.46万 - 项目类别:
相似海外基金
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 29.46万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 29.46万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 29.46万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 29.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 29.46万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 29.46万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 29.46万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 29.46万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 29.46万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 29.46万 - 项目类别:
Discovery Grants Program - Individual